IDIQ chemistry, manufacturing and controls and related services for development of drug products
Active Awarded Last action
- Contract number
- 75N95024D00036
- Awardee
-
Vitae Enim Vitae Scientific, Inc. UEI DXZ8K82VBBD5
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 1 $382,010 obligated
Award facts
- Opportunity
-
- Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products Pre-Solicitation · 75N95023R00037 · Posted May 30, 2023
- Combined order value
- $382,010 Current and potential, with all options
- Last date to order 32% complete
- IDV ceiling 1% used
- $49,885,703.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 8 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded a multiple-award indefinite-delivery contract to Vitae Enim Vitae Scientific, Inc. on August 1, 2024, with a ceiling of $49.885 million for chemistry, manufacturing and controls and related services for the development of drug products through July 31, 2031. No set-aside was used.
Performance occurs in San Diego, California. The IDIQ supports drug product development activities including dosage form reprocessing and stability studies. A delivery order issued on September 27, 2024, under firm fixed-price terms directed the contractor to conduct dosage form reprocess and stability studies of FX-5A injection, with a ceiling of $382,010 and completion scheduled by May 31, 2028.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Dosage form reprocess and stability studies of FX-5A injection under IDIQ chemistry, manufacturing and controls and… | National Institute on Drug Abuse (NIH) | $382,010 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00036?
75N95024D00036 was awarded to Vitae Enim Vitae Scientific, Inc. by National Institute on Drug Abuse (National Institutes of Health) on August 1, 2024.
How much is contract 75N95024D00036 worth?
Orders under 75N95024D00036 have obligated $382,010. 75N95024D00036's own ceiling is $49,885,703.
How many orders have been placed under contract 75N95024D00036?
1 order has been placed under 75N95024D00036, the latest on September 27, 2024.
Who can order from contract 75N95024D00036?
75N95024D00036 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract 75N95024D00036 part of a contract vehicle?
Yes. 75N95024D00036 is part of Chemistry, Manufacturing and Controls and Related Services for Development of Drug Products.
Was contract 75N95024D00036 competed?
The extent of competition for 75N95024D00036 was full and open competition. The government received 8 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV